MIT-MGB Seed Program
Forecasted
MIT-MGB Seed Program supports MIT and Mass General Brigham researchers and clinicians in joint research that develops or applies new technologies to transform clinical practice and address health problems.
Browse similar grants
Funder: Massachusetts Institute of Technology
Due Dates (Anticipated): June 2027 (Initial proposal submission)
Funding Amounts: Award types and amounts are available in the application portal
Summary: Supports joint MIT–Mass General Brigham research developing or applying new technologies to transform clinical practice.
Key Information: Projects must be joint research collaborations between MIT and Mass General Brigham.
Description
The MIT-MGB Seed Program is a collaboration between the Massachusetts Institute of Technology and Mass General Brigham, established with support from Analog Devices Inc. It supports joint research aimed at transforming clinical practice through the development or application of new technologies. The program brings MIT’s strengths in science, engineering, and innovation together with Mass General Brigham’s scientific and clinical research to address compelling problems in health and medicine.
Initial priorities include mental health and neurodegenerative disease, AI-enabled diagnostics, and digital health. Projects are evaluated for the potential impact of both the collaboration and the research, as well as their translatability. Funded work spans technology-enabled diagnosis, precision therapy delivery, engineered cell therapies, and patient-specific clinical tools.
